Adma Biologics ADMA
NASDAQ ADMA
$9.93 -0.10 (-1.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

Adma Biologics (ADMA) Non-Current Deffered Revenue (2015 - 2026)

Updated

Adma Biologics (ADMA) reported Non-Current Deffered Revenue of $1.33 million for Q2 2026, down 9.6% from $1.48 million a year earlier and down 2.6% from the prior quarter.

Analysis

Adma Biologics (ADMA) Non-Current Deffered Revenue (2015 - 2026) Analysis & Trends

At the end of FY2025, Adma Biologics posted Non-Current Deffered Revenue of $1.41 million, down 9.2% from FY2024.

  • Non-Current Deffered Revenue has declined for ten consecutive years, with a five-year compound annual growth rate of -7.9% (FY2020 to FY2025).
  • By year, Non-Current Deffered Revenue came in at $1.55 million in FY2024 (-8.5%), $1.69 million in FY2023 (-7.8%), $1.83 million in FY2022 (-7.2%) and $1.98 million in FY2021 (-6.7%).
  • The Q2 2026 figure ranks as the lowest quarterly Non-Current Deffered Revenue in data going back to Q4 2015.
  • Year over year, Non-Current Deffered Revenue has now declined in each of the last 20 quarters, with an average decline of 8.9% over the last eight quarters.
  • Over the past five years, the year-over-year decline in Non-Current Deffered Revenue ranged from 6.6% (Q3 2021) to 9.6% (Q2 2026).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $1.37 million (Q1 2026), $1.41 million (Q4 2025) and $1.44 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Adma Biologics 2.26 Bn 1.84 Bn 86.28 Mn 1.33 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.33 Mn
Mar 31, 2026 1.37 Mn
Dec 31, 2025 1.41 Mn
Sep 30, 2025 1.44 Mn
Jun 30, 2025 1.48 Mn
Mar 31, 2025 1.51 Mn
Dec 31, 2024 1.55 Mn
Sep 30, 2024 1.58 Mn
Jun 30, 2024 1.62 Mn
Mar 31, 2024 1.65 Mn
Dec 31, 2023 1.69 Mn
Sep 30, 2023 1.73 Mn
Jun 30, 2023 1.76 Mn
Mar 31, 2023 1.80 Mn
Dec 31, 2022 1.83 Mn
Sep 30, 2022 1.87 Mn
Jun 30, 2022 1.90 Mn
Mar 31, 2022 1.94 Mn
Dec 31, 2021 1.98 Mn
Sep 30, 2021 2.01 Mn
API Access

Adma Biologics Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ADMA&period=max&api_key=YOUR_API_KEY